Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-07-16 10:49 UTC

Lilly To Acquire AtaiBeckley For $6.75 Per Share In Cash Plus Up To $2.50 Per Share In A Contingent Value Right Dependent Upon Milestones Re

Eli Lilly and Company (NYSE: LLY ) and AtaiBeckley Inc. (NASDAQ: ATAI ), a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health conditions, today announced a definitive agreement for Lilly to acquire AtaiBeckley. AtaiBeckley is advancing a pipeline of rapid-acting neuroplastogen

ATAI LLY

News 2026-07-16 10:45 UTC

ATAI LLY(confirmed) lilly to acquire ataibeckley to advance Therapies for treatment-resistant depression and other mental health conditions

ATAI LLY(confirmed) lilly to acquire ataibeckley to advance Therapies for treatment-resistant depression and other mental health conditions Eli Lilly - to pay $6.75 per share cash plus up to $2.5 per share in cvr - Deal valued at $2.8B upfront with up to $1B in cvr - Deal expected to close in Q3 subject to approvals

ATAI LLY

Search market news

Matching instruments

Lilly To Acquire AtaiBeckley For $6.75 Per Share In Cash Plus Up To $2.50 Per Share In A Contingent Value Right Dependent Upon Milestones Re

ATAI LLY(confirmed) lilly to acquire ataibeckley to advance Therapies for treatment-resistant depression and other mental health conditions